Study offers new models for studying causes of chemo brain
Cancer is a challenging enough diagnosis, but many patients are dealt a second blow, even as they heal:…
Cyclic peptide nanotubes offer new route to overcome cancer drug resistance
A research team at CiQUS (University of Santiago de Compostela, Spain) has unveiled an innovative molecular approach that…
Cardiologist shares 5 everyday medications that silently damage the heart
How often do you pop a pill? For headaches, cold, diarrhea, constipation, itchy skin, acne – the list…
Boosting the immune system to prevent cancer recurrence and improve survival
In experiments with mouse models of breast, pancreatic, and muscle cancers, researchers at Johns Hopkins All Children’s Hospital…
Post-operative radiation therapy reduces pelvic relapse in high-risk bladder cancer
Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive…
Genetic variant linked to liver injury after chemotherapy in colorectal cancer patients
A new international study led by Mayo Clinic researchers has identified a genetic factor that may explain why some patients…
Mayo Clinic study finds genetic factor linked to liver damage in cancer patients | News
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a genetic factor that may explain why some colorectal cancer…
Nafisa Ali Sodhi opens up on battling Stage 4 cancer and disliking chemo: ‘It knocks you down with pain, fever, makes you feel bad’ | Hindi Movie News
Veteran actor and politician Nafisa Ali Sodhi, who first fought cancer in 2018, has once again found herself…
Magnetically-powered nanorobots enhance drug uptake in tumors
Spiky nanorobots powered by magnets have been developed to carry drugs and pierce tumor cell membranes, a key…
Survey shows ongoing misconceptions about hormone therapy safety in cancer survivors
Despite evidence suggesting the safety of hormone therapy for patients with a history of low-grade endometrial or epithelial…
Adjuvant chemo-immunotherapy may benefit patients with resected stage IB–IIIA NSCLC, trial suggests
Interim results from the NADIM ADJUVANT Phase III trial, led by the Spanish Lung Cancer Group (GECP), suggest…
Council Slashes GST On Key Medicines
How Patients Gain For families struggling with treatment bills, this comes across as a huge relief. Previously, a…